Kayo Ikeda

1.6k total citations
83 papers, 1.1k citations indexed

About

Kayo Ikeda is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Kayo Ikeda has authored 83 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pharmacology, 21 papers in Molecular Biology and 20 papers in Epidemiology. Recurrent topics in Kayo Ikeda's work include Antibiotics Pharmacokinetics and Efficacy (37 papers), Antibiotic Resistance in Bacteria (16 papers) and Pneumonia and Respiratory Infections (16 papers). Kayo Ikeda is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (37 papers), Antibiotic Resistance in Bacteria (16 papers) and Pneumonia and Respiratory Infections (16 papers). Kayo Ikeda collaborates with scholars based in Japan, United States and Australia. Kayo Ikeda's co-authors include Kazuro Ikawa, Norifumi Morikawa, Shingo Izawa, Yoshiharu Inoue, Hiroki Ohge, Taijiro Sueda, Tsutomu Masujima, Masanori Sugiyama, Shintaro Goto and Masao Kobayashi and has published in prestigious journals such as Immunity, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Kayo Ikeda

80 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kayo Ikeda Japan 19 410 342 239 182 159 83 1.1k
Michael S. Schwartz United States 22 375 0.9× 327 1.0× 253 1.1× 160 0.9× 355 2.2× 42 1.6k
Caroline Perry United States 19 334 0.8× 657 1.9× 272 1.1× 153 0.8× 216 1.4× 48 1.8k
F. Scaglione Italy 14 247 0.6× 189 0.6× 311 1.3× 105 0.6× 73 0.5× 66 806
Shuying Li China 18 140 0.3× 246 0.7× 251 1.1× 285 1.6× 62 0.4× 56 1.1k
Asad Mustafa Karim South Korea 13 98 0.2× 575 1.7× 186 0.8× 263 1.4× 138 0.9× 29 1.6k
Frederick B. Oleson United States 16 230 0.6× 351 1.0× 161 0.7× 94 0.5× 84 0.5× 26 1.2k
J. Van Eldere Belgium 19 176 0.4× 569 1.7× 189 0.8× 106 0.6× 141 0.9× 32 1.2k
Mercedes Gimeno Spain 17 240 0.6× 106 0.3× 285 1.2× 122 0.7× 128 0.8× 38 839
Rajiv L. Gaur United States 21 66 0.2× 309 0.9× 408 1.7× 116 0.6× 184 1.2× 27 1.3k
Yun‐Jeong Jeong South Korea 22 399 1.0× 584 1.7× 172 0.7× 43 0.2× 89 0.6× 59 1.3k

Countries citing papers authored by Kayo Ikeda

Since Specialization
Citations

This map shows the geographic impact of Kayo Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kayo Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kayo Ikeda more than expected).

Fields of papers citing papers by Kayo Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kayo Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kayo Ikeda. The network helps show where Kayo Ikeda may publish in the future.

Co-authorship network of co-authors of Kayo Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Kayo Ikeda. A scholar is included among the top collaborators of Kayo Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kayo Ikeda. Kayo Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinoshita, Shigeru, Takuya Watanabe, Kayo Ikeda, et al.. (2024). Space-filling experimental design for efficient Bayesian optimization. 1–4. 1 indexed citations
2.
Naik, Bhiken I., Claire Roger, Kayo Ikeda, et al.. (2017). Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trial. British Journal of Anaesthesia. 118(6). 876–882. 32 indexed citations
3.
Kinoshita, Makoto, Takashi Kusu, Hisako Kayama, et al.. (2015). The Ectoenzyme E-NPP3 Negatively Regulates ATP-Dependent Chronic Allergic Responses by Basophils and Mast Cells. Immunity. 42(2). 279–293. 68 indexed citations
4.
Ikawa, Kazuro, Kogenta Nakamura, Yoshiaki Yamada, et al.. (2013). Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation. International Journal of Antimicrobial Agents. 41(3). 267–271. 16 indexed citations
5.
Umeda, Satoshi, Hisayoshi Kawahara, Akihiro Yoneda, et al.. (2013). Impact of cow’s milk allergy on enterocolitis associated with Hirschsprung’s disease. Pediatric Surgery International. 29(11). 1159–1163. 7 indexed citations
6.
Yamada, Hiroyuki, Hiroki Kondou, Takeshi Kimura, et al.. (2012). Humoral immunity is involved in the development of pericentral fibrosis after pediatric live donor liver transplantation. Pediatric Transplantation. 16(8). 858–865. 30 indexed citations
7.
Yamada, Yoshiaki, Kazuro Ikawa, Kogenta Nakamura, et al.. (2011). Prostatic Penetration of Meropenem after Intravenous Administration in Patients Undergoing Transurethral Resection of the Prostate. Journal of Chemotherapy. 23(3). 179–180. 1 indexed citations
8.
Ikeda, Kayo, Shinobu Ida, Hisayoshi Kawahara, et al.. (2011). Importance of evaluating for cow's milk allergy in pediatric surgical patients with functional bowel symptoms. Journal of Pediatric Surgery. 46(12). 2332–2335. 8 indexed citations
9.
Ikawa, Kazuro, Norifumi Morikawa, Kayo Ikeda, et al.. (2010). Pharmacokinetic–pharmacodynamic target attainment analysis of meropenem in Japanese adult patients. Journal of Infection and Chemotherapy. 16(1). 25–32. 22 indexed citations
10.
Ikawa, Kazuro, et al.. (2009). Population pharmacokinetic modeling and pharmacodynamic assessment of cefozopran in pediatric patients.. PubMed. 62(5). 435–44. 3 indexed citations
11.
Ikeda, Kayo, Kazuro Ikawa, Norifumi Morikawa, Hiroki Ohge, & Taijiro Sueda. (2009). Determination of total cefozopran concentrations in human peritoneal fluid by HPLC with cefepime as an internal standard: Comparative pharmacokinetics in the fluid and plasma. Journal of Pharmaceutical and Biomedical Analysis. 49(4). 1075–1081. 7 indexed citations
12.
Ikawa, Kazuro, Norifumi Morikawa, Kayo Ikeda, Hiroki Ohge, & Taijiro Sueda. (2008). Pharmacodynamic evaluation of biapenem in peritoneal fluid using population pharmacokinetic modelling and Monte Carlo simulation. International Journal of Antimicrobial Agents. 32(4). 339–343. 6 indexed citations
13.
Ikawa, Kazuro, Norifumi Morikawa, Kayo Ikeda, et al.. (2008). Pharmacokinetic-pharmacodynamic target attainment analysis of cefozopran in Japanese adult patients. Journal of Infection and Chemotherapy. 14(2). 130–136. 9 indexed citations
14.
Ikawa, Kazuro, et al.. (2008). Population pharmacokinetics and pharmacodynamics of biapenem in paediatric patients. Journal of Clinical Pharmacy and Therapeutics. 33(2). 203–210. 4 indexed citations
15.
Ikawa, Kazuro, Norifumi Morikawa, Seiichi Hayato, et al.. (2007). Pharmacokinetic and pharmacodynamic profiling of cefepime in plasma and peritoneal fluid of abdominal surgery patients. International Journal of Antimicrobial Agents. 30(3). 270–273. 25 indexed citations
16.
Ikeda, Kayo, et al.. (2007). Real-time therapeutic drug monitoring of cefozopran in plasma using high-performance liquid chromatography with ultraviolet detection. Journal of Pharmaceutical and Biomedical Analysis. 45(5). 811–816. 8 indexed citations
17.
Ikawa, Kazuro, Norifumi Morikawa, Kayo Ikeda, et al.. (2007). Peritoneal penetration and pharmacodynamic exposure of intravenous cefozopran in abdominal surgery patients. International Journal of Antimicrobial Agents. 30(4). 352–355. 13 indexed citations
18.
Ikawa, Kazuro, et al.. (2006). Development of Software Support Tool for Planning Administration of Biapenem, a Carbapenem Antibacterial Agent, based on Pharmacokinetic/Pharmacodynamic Approach and Monte Carlo Simulation. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 32(7). 622–628. 6 indexed citations
19.
Ikeda, Kayo, Koji Suzuki, Hideki Yoshioka, et al.. (1998). Construction of a new cloning vector utilizing a cryptic plasmid and the highly expressed melanin-synthesizing gene operon fromStreptomyces castaneoglobisporus. FEMS Microbiology Letters. 168(2). 195–199. 5 indexed citations
20.
Masujima, Tsutomu, et al.. (1998). Trapping of Secreted Molecules at Single-Cell Level Using an HPLC Resin Particle Under a Videomicroscope.. Biological and Pharmaceutical Bulletin. 21(8). 886–888. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael S. Schwartz Breakdown of academic impact, for papers by Caroline Perry Breakdown of academic impact, for papers by F. Scaglione Breakdown of academic impact, for papers by Shuying Li Breakdown of academic impact, for papers by Asad Mustafa Karim Breakdown of academic impact, for papers by Frederick B. Oleson Breakdown of academic impact, for papers by J. Van Eldere Breakdown of academic impact, for papers by Mercedes Gimeno Breakdown of academic impact, for papers by Rajiv L. Gaur Breakdown of academic impact, for papers by Yun‐Jeong Jeong
Rankless by CCL
2026